These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 12373522

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR, Marjanska M, Wengenack TM, Reyes DA, Curran GL, Lin J, Preboske GM, Poduslo JF, Garwood M.
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [Abstract] [Full Text] [Related]

  • 5. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
    Wu ZL, Ciallella JR, Flood DG, O'Kane TM, Bozyczko-Coyne D, Savage MJ.
    Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
    [Abstract] [Full Text] [Related]

  • 6. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.
    DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM.
    Science; 2002 Mar 22; 295(5563):2264-7. PubMed ID: 11910111
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host.
    Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, Vigouret JM, Paganetti P, Walsh DM, Mathews PM, Ghiso J, Staufenbiel M, Walker LC, Jucker M.
    Science; 2006 Sep 22; 313(5794):1781-4. PubMed ID: 16990547
    [Abstract] [Full Text] [Related]

  • 11. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC, Yazdani U, Speciale SG, Pasbakhsh P, Games D, Liang CL.
    J Comp Neurol; 2003 Aug 04; 462(4):371-81. PubMed ID: 12811807
    [Abstract] [Full Text] [Related]

  • 12. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A, Julien C, Tremblay C, Berthiaume L, Julien P, Giguère Y, Calon F.
    Neuroscience; 2009 Mar 03; 159(1):296-307. PubMed ID: 19135506
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?
    Götz J, Ittner LM, Kins S.
    J Neurochem; 2006 Aug 03; 98(4):993-1006. PubMed ID: 16787410
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Loss of presenilin function causes Alzheimer's disease-like neurodegeneration in the mouse.
    Chen Q, Nakajima A, Choi SH, Xiong X, Tang YP.
    J Neurosci Res; 2008 May 15; 86(7):1615-25. PubMed ID: 18189321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.